Search for: "Wyeth Pharmaceuticals" Results 401 - 420 of 976
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2010, 10:41 am
The vaccine industry has opposed the Georgia ruling in a case in which the parents of a child claim their son suffered neurological damage after receiving vaccine booster shots made by pharmaceutical companies Wyeth and GlaxoSmithKline that contained the preservative thimerosal. [read post]
25 Oct 2012, 7:22 am by Christopher Walsh
., of the District of New Jersey has stayed several class-action litigations challenging the legality of certain reverse-payment settlement agreements between Wyeth and generic drug manufacturer Teva Pharmaceuticals, pursuant to which Wyeth allegedly paid Teva to delay its marketing of a generic counterpart to Wyeth’s Effexor XR drug. [read post]
18 Sep 2009, 2:40 am
Here are excerpts from the aticle: The drug, previously sold by Wyeth Pharmaceuticals Inc. under the brand name Phenergan, was at the heart of a U.S. [read post]
4 Feb 2009, 6:34 am
  Today she is at the center of a closely-watched Supreme Court case, Wyeth v Levine and a national debate about the federal courts and corporate accountability. [read post]
26 Jun 2013, 6:30 am by Gene Quinn
Pfizer subsidiary Wyeth and Takeda will divide the proceeds of the settlement with Pfizer receiving $1.376 billion and Takeda receiving $774 million. [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360)… [read post]
4 Jun 2011, 6:12 am by Walter Olson
Tags: Henry Waxman, obstetrics, pharmaceuticals Related posts Wyeth v. [read post]
9 Dec 2008, 2:48 am
  In this week’s call, regular panellist Jeremy Philips and Duncan Bucknell chat about: The recent increase in IP litigation in the UK; IP enforcement as a business decision; The European Commission report on the pharmaceutical industry; R&D incentives, competition law and ‘gaming the system’ in pharmaceuticals and other industries; Innovation strategies in new markets as against optimising existing markets; … [read post]
5 Aug 2009, 10:59 am
The documents suggest the practice went well beyond the case of Wyeth and hormone therapy, involving numerous drugs from other pharmaceutical companies. [read post]
5 Aug 2009, 1:05 pm
The documents suggest the practice went well beyond the case of Wyeth and hormone therapy, involving numerous drugs from other pharmaceutical companies. [read post]
5 Mar 2014, 2:46 pm
Wyeth Pharmaceuticals, Inc., Pennsylvania Supreme Court – propriety of punitive damages where defendant compl [read post]
28 Jun 2016, 9:02 am by Dean Freeman
Mensing limited generic drug makers’ pharmaceutical injury liability. [read post]
21 Sep 2007, 8:19 pm
Spicy IP has an interesting post this week on Indian pharmaceutical lifecycle management. [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment:… [read post]